Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand ...

Discover a study regime that included a treatment serum, a redness-reducing moisturizer, and sunscreen that showed promising ...

New research finds that topical ferulic acid significantly improves skin lesions and barrier function in patients with ...

Journey Medical (DERM) announced the FDA has approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi ...

Aviva Romm, a physician who specializes in integrative medicine. For generations, countless home remedies — cups of warm tea or soups and spoonfuls of herbs — have helped manage cold and flu ...

Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in adults, drugmaker Journey Medical ...

These eye masks are formulated to reduce the appearance of dark circles and puffiness while making you feel like you're ...

Journey Medical (DERM) announced that the FDA has approved Emrosi, formerly referred to as DFD-29, for the treatment of inflammatory lesions of ...

Journey Medical (DERM) received FDA approval for its drug Emrosi for the treatment of rosacea and released its preliminary Q3 ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Are you ready to dive into the ...

Journey Medical (DERM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...